Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.8.0.1
Condensed Balance Sheet - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 8,226,189 $ 11,578,473
Marketable securities 14,977,346 8,737,107
Prepaid expenses and other current assets 1,277,604 608,517
Total Current Assets 24,481,139 20,924,097
Security Deposits 30,785 30,785
Equipment, Net 79,056 88,650
Total Assets 24,590,980 21,043,532
Current Liabilities:    
Accounts payable and accrued expenses 2,338,777 1,882,500
Deferred Research and Development Arrangement 393,750 450,000
Other Liabilities 61,557 79,204
Warrant Liabilities 6,676,091 1,573,366
Total Liabilities 9,470,175 3,985,070
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 10,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 50,000,000 authorized shares, 28,459,805 and 23,736,878 issued and outstanding 2,846 2,374
Additional paid-in capital 151,858,173 132,086,419
Accumulated other comprehensive loss (13,965) (6,122)
Accumulated deficit (136,726,249) (115,024,209)
Total Stockholders' Equity 15,120,805 17,058,462
Total Liabilities and Stockholders' Equity $ 24,590,980 $ 21,043,532